Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,301 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastoma.
Adeberg S, Knoll M, Koelsche C, Bernhardt D, Schrimpf D, Sahm F, König L, Harrabi SB, Hörner-Rieber J, Verma V, Bewerunge-Hudler M, Unterberg A, Sturm D, Jungk C, Herold-Mende C, Wick W, von Deimling A, Debus J, Rieken S, Abdollahi A. Adeberg S, et al. Among authors: debus j. Acta Neuropathol. 2022 Jul;144(1):129-142. doi: 10.1007/s00401-022-02443-2. Epub 2022 Jun 4. Acta Neuropathol. 2022. PMID: 35660939 Free PMC article.
Endostatin's antiangiogenic signaling network.
Abdollahi A, Hahnfeldt P, Maercker C, Gröne HJ, Debus J, Ansorge W, Folkman J, Hlatky L, Huber PE. Abdollahi A, et al. Among authors: debus j. Mol Cell. 2004 Mar 12;13(5):649-63. doi: 10.1016/s1097-2765(04)00102-9. Mol Cell. 2004. PMID: 15023336 Free article.
Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection : Analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation.
Habermehl D, Lindel K, Rieken S, Haase K, Goeppert B, Büchler MW, Schirmacher P, Welzel T, Debus J, Combs SE. Habermehl D, et al. Among authors: debus j. Strahlenther Onkol. 2012 Sep;188(9):795-801. doi: 10.1007/s00066-012-0099-y. Epub 2012 Apr 13. Strahlenther Onkol. 2012. PMID: 22526232 Clinical Trial.
Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (head and neck cancer: immunochemo and radiotherapy with erbitux) - a multicenter phase IV trial.
Habl G, Potthoff K, Haefner MF, Abdollahi A, Hassel JC, Boller E, Indorf M, Debus J. Habl G, et al. Among authors: debus j. BMC Cancer. 2013 Jul 15;13:345. doi: 10.1186/1471-2407-13-345. BMC Cancer. 2013. PMID: 23855804 Free PMC article. Clinical Trial.
1,301 results